Hedge Fund - Armistice Capital
Supernus Pharmaceuticals Inc. (SUPN)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2024 - Q4 (2024-12-31) | $174,869,760 | 2.38% | 4,836,000 | $35.21 |
| 2 | 2024 - Q3 (2024-09-30) | $158,893,280 | 2.54% | 5,096,000 | $31.21 |
| 3 | 2024 - Q2 (2024-06-30) | $141,026,000 | 1.77% | 5,272,000 | $28.98 |
| 4 | 2024 - Q1 (2024-03-31) | $121,840,920 | 1.61% | 3,572,000 | $29.77 |
| 5 | 2023 - Q4 (2023-12-31) | $134,571,000 | 1.83% | 4,650,000 | $26.51 |
| 6 | 2023 - Q3 (2023-09-30) | $140,386,440 | 2.15% | 5,092,000 | $30.44 |
| 7 | 2023 - Q2 (2023-06-30) | $151,382,160 | 2.19% | 5,036,000 | $34.99 |
| 8 | 2023 - Q1 (2023-03-31) | $157,600,500 | 2.26% | 4,350,000 | $38.45 |
| 9 | 2022 - Q4 (2022-12-31) | $155,378,520 | 2.71% | 4,356,000 | $34.75 |
| 10 | 2022 - Q3 (2022-09-30) | $155,473,000 | 2.69% | 4,593,004 | $32.54 |
| 11 | 2022 - Q2 (2022-06-30) | $136,271,000 | 2.37% | 4,712,000 | $28.64 |
| 12 | 2022 - Q1 (2022-03-31) | $100,192,000 | 1.93% | 3,100,000 | $30.66 |
| 13 | 2021 - Q4 (2021-12-31) | $120,606,000 | 1.97% | 4,136,000 | $30.34 |
| 14 | 2021 - Q3 (2021-09-30) | $104,013,000 | 1.76% | 3,900,000 | $26.84 |
| 15 | 2021 - Q2 (2021-06-30) | $102,346,000 | 1.83% | 3,324,000 | $30.66 |
| 16 | 2021 - Q1 (2021-03-31) | $89,326,000 | 2.05% | 3,412,000 | $27.97 |
| 17 | 2020 - Q4 (2020-12-31) | $78,499,000 | 2.66% | 3,120,000 | $21.52 |
| 18 | 2020 - Q3 (2020-09-30) | $66,688,000 | 2.41% | 3,200,000 | $22.70 |
| 19 | 2020 - Q2 (2020-06-30) | $52,440,000 | 2.3% | 2,208,000 | $22.09 |
| 20 | 2020 - Q1 (2020-03-31) | $53,970,000 | 3.33% | 3,000,000 | $21.01 |
| 21 | 2019 - Q4 (2019-12-31) | $40,609,000 | 2.34% | 1,712,000 | $24.29 |
The displayed share prices are average quarterly stock market prices.